Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Wilkes Psychopharmacology NSG 552 Exam 1 Qs and Ans with Explanation (Latest 2025 / 2026), Exams of Nursing

Wilkes Psychopharmacology NSG 552 Exam 1 Qs and Ans with Explanation (Latest 2025 / 2026), Verified Revised Full Exam, Psychopharmacology NSG 552 Exam Wilkes Qs and Ans with Explanation (Latest 2025 / 2026), Verified Revised Full Exam, NSG 552 Psychopharmacology Exam Qs and Ans with Explanation (Latest 2025 / 2026), Wilkes, Verified Revised Full Exam, Pass Your (2025 / 2026) Wilkes NSG 552 Psychopharmacology Exam with (2 Version Exams) Qs and Ans with Explanation, Verified Revised Full Exam

Typology: Exams

2024/2025

Available from 04/15/2025

Lectjohn
Lectjohn 🇺🇸

4

(14)

564 documents

1 / 64

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
NSG552 / NSG 552 EXAM 1
Psychopharmacology - Wilkes
Actual Questions and Answers
100% Guarantee Pass
This Exam contains:
100% Guarantee Pass.
Multiple-Choice (A–D), For Each Question.
Each Question Includes The Correct Answer
Expert-Verified explanation
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22
pf23
pf24
pf25
pf26
pf27
pf28
pf29
pf2a
pf2b
pf2c
pf2d
pf2e
pf2f
pf30
pf31
pf32
pf33
pf34
pf35
pf36
pf37
pf38
pf39
pf3a
pf3b
pf3c
pf3d
pf3e
pf3f
pf40

Partial preview of the text

Download Wilkes Psychopharmacology NSG 552 Exam 1 Qs and Ans with Explanation (Latest 2025 / 2026) and more Exams Nursing in PDF only on Docsity!

NSG552 / NSG 552 EXAM 1

Psychopharmacology - Wilkes

Actual Questions and Answers

100% Guarantee Pass

This Exam contains:

 100% Guarantee Pass.

 Multiple-Choice (A–D), For Each Question.

 Each Question Includes The Correct Answer

 Expert-Verified explanation

  1. Question: Increases serum levels of other drugs that are substrates of that enzyme.

Answer: Enzyme inhibitors Explanation: Enzyme inhibitors, particularly those affecting the cytochrome P450 system, reduce the metabolism of substrates they affect, subsequently raising their serum concentrations. This can lead to potentially dangerous toxic levels, making it critical for healthcare providers to monitor drug interactions and adjust dosages accordingly in patients on polypharmacy.

  1. Question: Decreases serum levels of other drugs that are substrates of that enzyme.

Answer: Enzyme inducers Explanation: Enzyme inducers enhance the metabolic activity of certain enzymes, resulting in faster clearance of substrate drugs and lower serum levels. This effect can lead to subtherapeutic drug concentrations, which may necessitate dosage adjustments to maintain efficacy. Recognizing induction effects is important for clinicians managing medications in patients with complex treatment regimens.

  1. Question: Part of the brain that regulates powerful emotions such as fear, rage, and sexual desires.

Answer: Amygdala Explanation: The amygdala is a crucial component of the limbic system and plays a central role in processing emotions, particularly negative emotions like fear and aggression. Its functioning is essential for the

interaction, and impulse control. It regulates planning and execution of tasks and is heavily involved in personality characteristics. Dysfunction in this area can contribute to a variety of psychiatric conditions, such as ADHD and schizophrenia.

  1. Question: The study of the use of psychotropic medications in the treatment of psychiatric disorders.

Answer: Psychopharmacology Explanation: Psychopharmacology is the field that explores the effects of medications on mood, behavior, and psychiatric symptoms. It involves examining how various classes of psychotropic drugs, such as antidepressants, antipsychotics, and anxiolytics, are utilized to manage mental health disorders. This discipline is essential for mental health professionals as it informs treatment plans and medication management strategies.

  1. Question: The study of what the body does to drugs.

Answer: Pharmacokinetics Explanation: Pharmacokinetics focuses on the processes of absorption, distribution, metabolism, and excretion (ADME) of drugs within the body. It provides insight into how different factors—such as age, weight, and organ function—affect drug action and dosing parameters, which is crucial for ensuring effective and safe medication use in psychiatric care.

  1. Question: The study of what the drug does to the body.

Answer: Pharmacodynamics

Explanation: Pharmacodynamics examines the biochemical, physiological, and molecular effects of drugs on the body. It investigates how medications interact with receptors, alter neurotransmitter systems, and ultimately produce therapeutic or adverse effects. In psychiatry, understanding pharmacodynamics is vital to selecting appropriate medications that effectively target specific symptoms.

  1. Question: Involves the absorption, distribution, metabolism, and excretion of meds.

Answer: Pharmacokinetics (not First Pass Metabolism) Explanation: Pharmacokinetics encompasses the full scope of how drugs are absorbed into the bloodstream, distributed throughout the body, metabolized by enzymatic activity (often in the liver), and excreted, primarily by the kidneys. First-pass metabolism is a specific aspect of metabolism that describes how drugs are processed by the liver before reaching systemic circulation, affecting their bioavailability.

  1. Question: Derived from Tryptophan and made in the Raphe Nuclei.

Answer: Serotonin Explanation: Serotonin is a critical neurotransmitter synthesized from tryptophan primarily in the raphe nuclei of the brainstem. It is involved in regulating mood, anxiety, and overall emotional balance. Dysregulation of serotonin levels is linked to various psychiatric disorders, notably depression and anxiety, making its modulation a target for many antidepressant therapies.

including the mesolimbic, mesocortical, nigrostriatal, and tuberoinfundibular pathways, play important roles in regulating mood, motivation, pleasure, and motor control, linking dopamine dysregulation to various psychiatric disorders and substance use.

  1. Dopamine inhibits prolactin in this pathway:

Answer: Tuberoinfundibular Explanation: The tuberoinfundibular pathway is responsible for inhibiting the release of prolactin from the anterior pituitary gland through dopamine, which acts as a prolactin-inhibiting factor. Dysfunction or blockade of dopamine receptors in this pathway can lead to hyperprolactinemia, resulting in side effects such as galactorrhea or gynecomastia.


  1. Increase dopamine in this pathway is associated with positive symptoms:

Answer: Mesolimbic Pathway Explanation: The mesolimbic pathway is primarily associated with the experience of pleasure and reward. An increase in dopamine activity in this pathway is believed to underlie the positive symptoms of schizophrenia, such as hallucinations and delusions. This pathway's hyperactivity is a target for antipsychotic medications, which aim to reduce excessive dopamine signaling.

  1. Decrease dopamine in this pathway is associated with negative symptoms:

Answer: Mesocortical Pathway Explanation: The mesocortical pathway connects the mesencephalon to the prefrontal cortex and modulates motivation, emotion, and cognition. Decreased dopamine transmission in this pathway can lead to the negative symptoms of schizophrenia, including apathy, anhedonia, and social withdrawal. Understanding this relationship is essential in developing treatment strategies that target these symptoms.

  1. Decrease dopamine in this pathway produces motor symptoms:

Answer: Nigrostriatal Pathway Explanation: The nigrostriatal pathway, which connects the substantia nigra to the striatum, is primarily involved in the regulation of movement. A decrease in dopamine within this pathway, often due to antipsychotic medications, can lead to motor symptoms such as bradykinesia, rigidity, and tremors, resembling Parkinson's disease and termed drug-induced parkinsonism.

  1. Main inhibitory neurotransmitter that induces calmness and relaxation:
  1. Electrolyte imbalance commonly associated with psychotropic medication use:

Answer: Hyponatremia Explanation: Hyponatremia, or low sodium levels in the blood, can occur as a side effect of some psychotropic medications, particularly in older adults or when there is increased water intake. It is vital to monitor electrolyte levels in patients on certain antidepressants and antipsychotics, as symptomatic hyponatremia can lead to significant health complications.

  1. The time needed to clear 50% of drugs from the plasma:

Answer: Half-life Explanation: The half-life of a drug is the time required for the concentration of the drug in the bloodstream to reduce to half its initial value. This pharmacokinetic parameter is crucial for determining dosing intervals and frequency, ensuring effective therapeutic levels while minimizing toxicity.


  1. The process of becoming desensitized and less responsive to a particular medication dose over time necessitating an increase:

Answer: Tolerance

Explanation: Tolerance refers to the phenomenon where a patient experiences diminishing effects from a medication after prolonged use, often leading to the need for higher doses to achieve the same therapeutic effect. This concept is significant in the management of chronic pain or anxiety disorders, where adjustments in medication may be required.

  1. A ratio describing toxic dose to effective dose:

Answer: Therapeutic Index Explanation: The therapeutic index is a measure of the safety of a drug, calculated by comparing the toxic dose to the effective dose. A higher therapeutic index indicates a larger margin of safety, which is essential in psychopharmacology, as it informs dosing decisions to minimize adverse effects while maximizing therapeutic benefit.

  1. A chemical that binds to a receptor to produce a biological response:

Answer: Agonist Explanation: Agonists are substances that bind to and activate receptors, mimicking the effects of endogenous neurotransmitters. Understanding the role of agonists is crucial in drug development and therapy for psychiatric conditions, as they can enhance or restore impaired neurotransmitter systems.

Explanation: Inverse agonists bind to the same receptors as agonists but lead to the opposite effect, reducing receptor activity. The study of inverse agonists is relevant in the context of psychopharmacology, as they may provide alternative therapeutic strategies for certain conditions.

  1. A usually undesired but foreseeable effect that occurs regardless of dose and often resolves after continued therapy:

Answer: Side Effects Explanation: Side effects are unintended reactions to medications that can occur despite appropriate dosing. While some side effects may resolve over time, others may require adjustments to medication regimens or strategies for management, emphasizing the importance of ongoing patient monitoring.

  1. S/S opposite of what it was meant to treat:

Answer: Paradoxical Reaction Explanation: Paradoxical reactions are responses that are opposite to the intended therapeutic effect of a medication. Understanding these atypical responses is crucial in clinical practice, as they can complicate treatment and necessitate alternative interventions.

  1. The four main dopamine pathways:

Answer: Mesolimbic, mesocortical, nigrostriatal, tuberoinfundibular Explanation: The four primary dopamine pathways are essential for understanding the neurobiology of schizophrenia and other psychiatric disorders. Each of these pathways plays distinct roles in behavior, cognition, and motor control, highlighting the complexity of dopamine's actions in the brain.


  1. Symptoms of Schizophrenia are divided into BLANK and BLANK:

Answer: Positive and negative symptoms Explanation: Schizophrenia symptoms are classified as positive (e.g., hallucinations, delusions) and negative (e.g., affective flattening, social withdrawal). This classification aids in understanding the disorder's multifaceted nature and informs treatment approaches targeting specific symptom domains.

  1. True or False: Antipsychotic polypharmacy can increase the risk of re- hospitalization, diabetes, E.P.S., sedation, seizures, metabolic effects, mortality, and sudden cardiac death:

Answer: True Explanation: Polypharmacy in antipsychotic treatment can lead to serious adverse effects and complicate the clinical management of patients.

Explanation: Typical antipsychotics, primarily dopamine antagonists, were the first class developed for treating schizophrenia. Their primary role in the management of positive symptoms is well-documented, but they can also lead to significant extrapyramidal side effects.

  1. Another name for 2nd generation antipsychotics:

Answer: Atypical Explanation: Atypical antipsychotics differ from typical antipsychotics in their mechanism of action, offering efficacy against both positive and negative symptoms while often having a reduced risk of extrapyramidal side effects. This class represents an important advancement in psychopharmacological therapy.


  1. First line treatment for Schizophrenia:

Answer: Atypical Explanation: Atypical antipsychotics are generally considered the first line of treatment for schizophrenia due to their favorable efficacy and side effect profile compared to typical antipsychotics. They are particularly useful in targeting both positive and negative symptoms.


  1. This class is associated with fewer neurological side effects and effective for both positive and negative symptoms:

Answer: Atypical Explanation: Atypical antipsychotics are designed to minimize neurological side effects, such as extrapyramidal symptoms, while effectively treating both the positive and negative symptoms associated with schizophrenia. Their broader therapeutic profile makes them advantageous in clinical practice.


  1. This class is effective for only positive symptoms and can in fact worsen negative symptoms due to decrease DA in the Mesocortical pathway:

Answer: Typical Explanation: Typical antipsychotics primarily target positive symptoms but may exacerbate negative symptoms by decreasing dopamine levels in the mesocortical pathway. Understanding this side effect mechanism is important for clinicians when devising treatment strategies.

  1. Associated with metabolic side effects:

Answer: Atypical Explanation: Atypical antipsychotics are known for their association with metabolic side effects, including weight gain, diabetes, and dyslipidemia.

Answer: Haldol Explanation: Haloperidol is often used in emergency settings for rapid control of acute agitation and psychotic episodes. Its potent effects make it a preferred choice for immediate intervention in severely agitated patients.

  1. Includes medications such as Olanzapine, Quetiapine, Risperidone, Clozapine etc.:

Answer: Atypical Explanation: These medications represent the atypical antipsychotics, distinguished by their dual receptor activity (dopamine and serotonin receptor modulation), leading to improvements in both positive and negative symptoms while generally posing fewer extrapyramidal side effects.

  1. F.G.A. reduce dopamine transmission by blocking BLANK receptors:

Answer: D Explanation: First-generation antipsychotics primarily exert their therapeutic effects by antagonizing D2 dopamine receptors, which helps mitigate positive symptoms. However, this action can also lead to unwanted motor side effects due to reduced dopamine activity in the nigrostriatal pathway.

  1. S.G.A. block both BLANK and BLANK receptors:

Answer: D2 and 5HT2A Explanation: Second-generation antipsychotics target both D2 dopamine receptors and 5HT2A serotonin receptors, which is theorized to enhance their efficacy for both positive and negative symptoms while minimizing extrapyramidal symptoms.


  1. High incidence of Q.T.C. prolongation, Tardive dyskinesia, Neuroleptic Malignant Syndrome (N.M.S.), orthostatic hypotension:

Answer: Typical Explanation: Typical antipsychotics are associated with a higher risk of serious side effects including QTc prolongation, tardive dyskinesia, and neuroleptic malignant syndrome, necessitating careful monitoring and management when these medications are prescribed.


  1. H1 blockade leads to symptoms of BLANK and BLANK:

Answer: Sedation and weight gain Explanation: Antagonism of H1 histamine receptors contributes to sedative effects and weight gain in patients taking atypical antipsychotics. Clinicians must consider these side effects when prescribing and monitoring antipsychotic medications.